162 related articles for article (PubMed ID: 16597196)
21. Amyotrophic lateral sclerosis--the tools of the trait.
Lederer CW; Santama N
Biotechnol J; 2007 May; 2(5):608-21. PubMed ID: 17345579
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial agents: the new theriac?
Labro MT
Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1363-5. PubMed ID: 23253312
[No Abstract] [Full Text] [Related]
23. Impact of proteomics on bladder cancer research.
Celis JE; Gromova I; Moreira JM; Cabezon T; Gromov P
Pharmacogenomics; 2004 Jun; 5(4):381-94. PubMed ID: 15165174
[TBL] [Abstract][Full Text] [Related]
24. Progress and problems in the exploration of therapeutic targets.
Zheng C; Han L; Yap CW; Xie B; Chen Y
Drug Discov Today; 2006 May; 11(9-10):412-20. PubMed ID: 16635803
[TBL] [Abstract][Full Text] [Related]
25. How shall we use the proteomics toolbox for biomarker discovery?
Lescuyer P; Hochstrasser D; Rabilloud T
J Proteome Res; 2007 Sep; 6(9):3371-6. PubMed ID: 17655344
[TBL] [Abstract][Full Text] [Related]
26. Host-directed drug targeting of factors hijacked by pathogens.
Schwegmann A; Brombacher F
Sci Signal; 2008 Jul; 1(29):re8. PubMed ID: 18648074
[TBL] [Abstract][Full Text] [Related]
27. The future of proteomic analysis in biological systems and molecular medicine.
Bark SJ; Hook V
Mol Biosyst; 2007 Jan; 3(1):14-7. PubMed ID: 17216050
[TBL] [Abstract][Full Text] [Related]
28. Optimization and delivery of plasmid DNA for vaccination.
Jechlinger W
Expert Rev Vaccines; 2006 Dec; 5(6):803-25. PubMed ID: 17184219
[TBL] [Abstract][Full Text] [Related]
29. Primary amine coding as a path to comparative proteomics.
Regnier FE; Julka S
Proteomics; 2006 Jul; 6(14):3968-79. PubMed ID: 16800033
[TBL] [Abstract][Full Text] [Related]
30. Use of proteomics for the identification of novel drug targets in brain diseases.
Morón JA; Devi LA
J Neurochem; 2007 Jul; 102(2):306-15. PubMed ID: 17419802
[TBL] [Abstract][Full Text] [Related]
31. Quantitative proteomics: the next logical step in molecular phenotyping.
Veenstra TD; Blonder J
Brief Funct Genomic Proteomic; 2009 Mar; 8(2):89. PubMed ID: 19398504
[No Abstract] [Full Text] [Related]
32. Can we help one billion sick people?
Maliski E; Gund P; Brown F
Curr Opin Drug Discov Devel; 2008 May; 11(3):301-2. PubMed ID: 18428082
[No Abstract] [Full Text] [Related]
33. [Treatment of infectious diseases in a public health care center].
Groop L; Forsén B; Niemelä R; Pitkänen MR; Källström KE
Duodecim; 1980; 96(3):200-5. PubMed ID: 7449668
[No Abstract] [Full Text] [Related]
34. Engineering sweet targets for magic bullets.
Feizi T
Nat Biotechnol; 2004 Oct; 22(10):1244-5. PubMed ID: 15470462
[No Abstract] [Full Text] [Related]
35. [Application of proteomics to diagnosis and treatment of lung cancer].
Dai M; Luo RC
Ai Zheng; 2007 Jun; 26(6):669-72. PubMed ID: 17562279
[TBL] [Abstract][Full Text] [Related]
36. Use of scoring to induce reproducible drug delivery from osmotic pulsatile tablets.
Rahemba TR; Bell S; Connolly EK; Waterman KC
Pharm Dev Technol; 2009; 14(5):548-55. PubMed ID: 19552560
[TBL] [Abstract][Full Text] [Related]
37. Vaginal microbicides: the importance of effective distribution, retention and coating of the mucosa.
das Neves J; Santos B; Cunha T; Teixeira B; Rocha P; Dias G
AIDS; 2008 Apr; 22(7):908-9. PubMed ID: 18427214
[No Abstract] [Full Text] [Related]
38. Novel Agents for Antimicrobial Solutions.
Mohammadzadeh R
Eye Contact Lens; 2016 Nov; 42(6):401-402. PubMed ID: 27798495
[No Abstract] [Full Text] [Related]
39. Synthetic combinatorial libraries as an alternative strategy for the development of novel treatments for infectious diseases.
Blondelle SE; Pinilla C; Boggiano C
Methods Enzymol; 2003; 369():322-44. PubMed ID: 14722962
[No Abstract] [Full Text] [Related]
40. The impact of genomics on discovering drugs against infectious diseases.
Boshoff HI; Manjunatha UH
Microbes Infect; 2006 May; 8(6):1654-61. PubMed ID: 16690340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
